Acidification of Blood Is Superior to Sodium Fluoride Alone as an Inhibitor of Glycolysis

被引:122
作者
Gambino, Raymond [1 ]
Piscitelli, Janet [1 ]
Ackattupathil, Tomy A. [1 ]
Theriault, Judy L. [1 ]
Andrin, Reynaldo D. [1 ]
Sanfilippo, Michael L. [1 ]
Etienne, Monina [1 ]
机构
[1] Quest Diagnost, Deerfield Beach, FL 33442 USA
关键词
PLASMA-GLUCOSE; RECOMMENDATIONS; DIAGNOSIS; IMPACT;
D O I
10.1373/clinchem.2008.121707
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BACKGROUND: Sodium fluoride is the preferred agent to inhibit glycolysis. Its action is not immediate, however, and complete inhibition is delayed for up to 4 hours. A more effective method is needed. Acidification of blood combined with the addition of NaF and EDTA appears to be such a method. We studied whether acidification was indeed more effective than NaF. METHODS: We conducted 6 independent studies over a 10-month period at 3 Quest Diagnostics laboratory sites. In each study, we drew venous blood from 6-24 nonfasting employee volunteers into 3 or 4 different serum- or plasma-collection tubes, which were stored under different conditions and aliquoted at different times. We analyzed the aliquots in duplicate by means of a hexokinase-based enzymatic method. RESULTS: The mean glucose concentration decreased by 0.3% at 2 h and by 1.2% at 24 h when blood was drawn into tubes containing citrate buffer, NaF, and EDTA. In contrast, the mean glucose concentration decreased by 4.6% at 2 h and by 7.0% at 24 h when blood was drawn into tubes containing NaF and sodium oxalate. CONCLUSIONS: Acidification should replace NaF alone as the recommended method for obtaining an accurate glucose concentration. Diagnostic cut points based on blood samples collected into tubes containing NaF as the only inhibitor of glycolysis are likely to be too low.
引用
收藏
页码:1019 / 1021
页数:3
相关论文
共 8 条
  • [1] CHAN AYW, 1989, CLIN CHEM, V35, P315
  • [2] Gambino R, 2006, NEW ENGL J MED, V354, P87
  • [3] Stabilization of glucose in blood specimens: Mechanism of delay in fluoride inhibition of glycolysis
    Mikesh, Leann M.
    Bruns, David E.
    [J]. CLINICAL CHEMISTRY, 2008, 54 (05) : 930 - 932
  • [4] Sacks DB, 2002, CLIN CHEM, V48, P436, DOI 10.2337/dc11-9998
  • [5] Stahl M, 2001, SCAND J CLIN LAB INV, V61, P169
  • [6] A NEW METHOD OF INHIBITING GLYCOLYSIS IN BLOOD-SAMPLES
    UCHIDA, K
    MATUSE, R
    TOYODA, E
    OKUDA, S
    TOMITA, S
    [J]. CLINICA CHIMICA ACTA, 1988, 172 (01) : 101 - 108
  • [7] Uchida K, 1988, US patent, Patent No. [4,780,419, 4780419]
  • [8] Glycolysis inhibitors negatively bias blood glucose measurements: potential impact on the reported prevalence of diabetes mellitus
    Waring, W. S.
    Evans, L. E.
    Kirkpatrick, C. T.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (07) : 820 - 823